Xiamen Amoytop Biotech Co., Ltd. (SHA: 688278)
China
· Delayed Price · Currency is CNY 73.55
+0.15 (0.20%)
Dec 31, 2024, 1:32 PM CST
Xiamen Amoytop Biotech Market Cap
Xiamen Amoytop Biotech has a market cap or net worth of 29.42 billion as of January 6, 2025. Its market cap has increased by 32.80% in one year.
Market Cap
29.42B
Enterprise Value
28.84B
Revenue
2.60B
Ranking
n/a
PE Ratio
39.73
Stock Price
73.55
Market Cap Chart
Since January 17, 2020, Xiamen Amoytop Biotech's market cap has increased from 14.36B to 29.42B, an increase of 104.84%. That is a compound annual growth rate of 15.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 3, 2025 | 29.90B | 0.19% |
| Dec 31, 2024 | 29.85B | 40.15% |
| Dec 29, 2023 | 21.30B | 34.47% |
| Dec 30, 2022 | 15.84B | 32.96% |
| Dec 31, 2021 | 11.91B | -14.13% |
| Dec 31, 2020 | 13.87B | -3.40% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shenzhen Mindray Bio-Medical Electronics | 294.68B |
| Jiangsu Hengrui Medicine | 282.07B |
| WuXi AppTec | 150.20B |
| Zhangzhou Pientzehuang Pharmaceutical., | 123.98B |
| Aier Eye Hospital Group | 116.12B |
| Shanghai United Imaging Healthcare | 103.88B |
| Yunnan Baiyao Group Co.,Ltd | 103.36B |
| Beijing Wantai Biological Pharmacy Enterprise | 89.42B |